AI Summary
Isomorphic Labs, a drug discovery company linked to Google DeepMind, is negotiating to raise over $2 billion in funding. Thrive Capital, which previously led the company's initial funding round, is expected to lead this new financing, with participation from Alphabet.
- Isomorphic Labs is an AI-driven drug discovery firm that originated from Google DeepMind.
- The company is in advanced discussions to raise more than $2 billion in a new funding round.
- Thrive Capital, which led Isomorphic Labs' first funding round last year, is set to lead this new financing.
- Alphabet is also expected to participate in the funding round, which has not yet been finalized.
fundingdrug discoveryisomorphic labsgoogledeepmind